HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An exploratory investigation of links between changes in adipokines and quality of life in individuals undergoing weight loss interventions: possible implications for cancer research.

AbstractOBJECTIVE:
Obesity has been linked to a wide spectrum of malignancies, with the strongest association demonstrated for endometrial cancer. Although the mechanisms are not yet entirely clear, a number of risk biomarkers have been proposed, including altered adipokines. Systemic levels of these adipose derived molecules have also been linked in prior research to self-reported quality of life (QOL). The study objective was to examine the hypothesis that adipokine changes during intentional weight loss may be associated with changes in QOL.
METHODS:
Fifty-two female participants were selected from two behavioral weight loss trials (SMART and PREFER) on the basis of achieving successful weight loss at 6month assessment, availability of blood samples and completion of standard SF-36 QOL questionnaires. Levels of adiponectin, leptin, and resistin were measured using xMAP immunoassays. Changes in QOL were examined using linear regression models in relation to pre- and post-intervention changes in biomarker levels and BMI.
RESULTS:
Significant changes between pre- and post-intervention were observed for leptin. Controlling for baseline BMI, leptin was the only biomarker that predicted change in QOL (Physical Component Scale, PCS). Linear regression models demonstrated that leptin continued to be a significant predictor of change in PCS when other possible predictor variables were included in the model.
CONCLUSIONS:
This study is among the first to demonstrate that changes in PCS may be regulated by levels of both metabolic variables and adipokines. An improved understanding of biological mechanisms associated with weight loss and the role of QOL may help guide preventive strategies for obesity-associated cancers.
AuthorsFaina Linkov, Lora E Burke, Marina Komaroff, Robert P Edwards, Anna Lokshin, Mindi A Styn, Eugene Tseytlin, Kyle E Freese, Dana H Bovbjerg
JournalGynecologic oncology (Gynecol Oncol) Vol. 133 Issue 1 Pg. 67-72 (Apr 2014) ISSN: 1095-6859 [Electronic] United States
PMID24462731 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • ADIPOQ protein, human
  • Adipokines
  • Adiponectin
  • Leptin
  • RETN protein, human
  • Resistin
Topics
  • Adipokines (metabolism)
  • Adiponectin (metabolism)
  • Adult
  • Body Mass Index
  • Female
  • Humans
  • Leptin (metabolism)
  • Linear Models
  • Middle Aged
  • Obesity (metabolism, therapy)
  • Overweight (metabolism, therapy)
  • Quality of Life
  • Resistin (metabolism)
  • Weight Loss (physiology)
  • Weight Reduction Programs
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: